Bristol-Myers (BMY) ROE US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| ROE, % | ? | 19.5% | 20.4% | 27.3% | -54.8% | 38.2% | 36.3% | |
| Changes by years, y/y, % | +43pp | +1pp | +7pp | -82pp | +93pp | |||
Bristol-Myers. ROE, %
Bristol-Myers. ROE, changes, pp
Bristol-Myers (BMY) ROE US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| ROE, % | ? | 31.2% | 29.0% | 32.6% | 38.2% | 36.3% | 36.3% | |
| Changes by years, y/y, % | +68pp | +67pp | +75pp | +93pp | +5pp | |||
| Changes by quarters, q/q, % | +86pp | -2pp | +4pp | +6pp | -2pp | |||